Market Research Logo

Latin America Glucose Monitoring System Market Forecast 2018-2026

Latin America Glucose Monitoring System Market Forecast 2018-2026

KEY FINDINGS
The Latin America Continuous Glucose Monitoring System (CGMS) market stood at $47.6 million in 2017 and is expected to reach $865.3 million by 2026, exhibiting a CAGR of 37.94% over the forecast period of 2018-2026.
Also, the Latin America Self-Monitoring of Blood Glucose (SMBG) market is expected to rise from $560.2 billion in 2017 to $1489.7 by 2026, exhibiting a CAGR of 11.61% over the said forecasted period.

MARKET INSIGHTS
According to some researches, Latin America is expected to have a diabetic population of around 14%, which is further expected to exceed. Rapid urbanization, increases in life expectancy and changing lifestyle are some of the major contributing factors for this increase. The prevalence rate of type 2 diabetes in Latin America is more than that of Type 1. One of the major challenges faced by this region is that half of the patients remain undiagnosed and the effectiveness of treatment programs is below the international standards, thus resulting in high expenditures. Due to this same reason, governments of these countries have called for more investments from big pharmaceuticals in their industries.

COMPETITIVE INSIGHTS
Companies like Sanofi, Novartis, Cristalia, Boehringer Ingelheim, GlaxoSmithKline, Hipolabor, etc. are the top pharmaceutical companies dealing in this region.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Study Market
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.2. Bottom-up Approach
2.3. Top Down Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Cgms Market Is Anticipated To Be A Developed Market
3.2.2. Self-monitoring Of Blood Glucose Has Huge Market Opportunity
3.2.3. Collaboration Of Significant Companies To Develop Integrated Cgms-enabled Insulin Pumps
4. Market Overview
4.1. Drivers And Impact
4.1.1. Rise In The Incidence Of Diabetes
4.1.2. Increase In Healthcare Expenditure
4.1.3. Increasing Focus On Research And Development
4.1.4. Technology Integration
4.1.5. Increasing Cgms And Smbg Affordability
4.1.6. Technological Advances In Gms Devices
4.1.7. Awareness Among The General Population
4.2. Restrain And Impact
4.2.1. Hinderance From Government Regulations
4.2.2 Inadequate Reimbursement Options For Continuous Glucose Monitoring Devices
4.2.3. Lack Of Awareness Of The Diagnostic Opportunities
4.3. Challenges
4.3.1. Intense Competition Among Vendors
4.3.2. Inaccuracy In Reading Of Gms Devices
4.3.3. Increasingly Stringent Government Regulations
5. Cgms Market Segmentation
5.1. Market By Component Type 2018-2026
5.1.1. Sensors
5.1.2. Transmitters And Receivers
5.1.3. Insulin Pump
5.2. Market By End Users 2018-2026
5.2.1. Home Settings
5.2.2. Diagnostics And Clinics
5.2.3. Hospitals
6. Smbg Market
7. Smbg Market Segmentation
7.1. Market By Component Type 2018-2026
7.1.1. Test Strips
7.1.2. Glucose Meter
7.1.3. Lancets
7.2. Market By End Users 2018-2026
7.2.1. Home Settings
7.2.2. Clinics
7.2.3. Hospitals
8. Key Analytical
8.1. 5 Forces Analysis
8.1.1. Threat Of New Entrant
8.1.2. Threat Of Substitute Products Or Services
8.1.3. Bargaining Power Of Buyers
8.1.4. Bargaining Power Of Supplier
8.1.5. Intensity Of Competitive Rivalry
8.2. Merger And Acquisitions
8.3. Key Buying Criteria
8.4. Key Trends
8.4.1. Development Of High-quality Wearable Devices
8.4.2. Mobile Healthcare Making The Devices More User-friendly
8.4.3. Increasing Efforts Towards Spread Of Awareness
8.4.4. Increase In Non-invasive Devices
8.4.5. Energy Harvesting Technology For Uninterrupted Usage
8.5. Regulation Of Blood Sugar
8.6. Incidence And Prevalence Of Diabetes For Various Countries
9. Regional Analysis
9.1. Latin America
9.1.1. Brazil Health And Healthcare
9.1.2. Brazil Pharmaceutical Market
9.1.3. Mexico Health And Healthcare
9.1.4. Mexico Pharmaceutical Market
10. Competitive Landscape
10.1. Medtronic
10.1.1. Overview
10.1.2. Product Portfolio
10.1.3. Strategic Initiatives
10.1.4. Scot Analysis
10.2. Dexcom
10.2.1. Overview
10.2.2. Product Portfolio
10.2.3. Strategic Initiatives
10.2.4. Scot Analysis
10.3. Abbott
10.3.1. Overview
10.3.2. Product Portfolio
10.3.3. Strategic Initiatives
10.3.4. Scot Analysis
10.4. Johnson And Johnson
10.4.1. Overview
10.4.2. Product Portfolio
10.4.3. Strategic Initiatives
10.4.4. Scot Analysis
10.5. Insulet Corp
10.5.1. Overview
10.5.2. Product Portfolio
10.5.3. Strategic Initiatives
10.5.4. Scot Analysis
10.6. Tandem Diabetes Care
10.6.1. Overview
10.6.2. Product Portfolio
10.6.3. Strategic Initiatives
10.6.4. Scot Analysis
10.7. Echo Therapeutics Inc
10.7.1. Overview
10.7.2. Product Portfolio
10.7.3. Strategic Initiatives
10.7.4. Scot Analysis
10.8. Roche Diagnostics
10.8.1. Overview
10.8.2. Product Portfolio
10.8.3. Strategic Initiatives
10.8.4. Scot Analysis
10.9. Nemaura Medical Inc
10.9.1. Overview
10.9.2. Product Portfolio
10.9.3. Strategic Initiatives
10.9.4. Scot Analysis
10.10. Senseonics Inc
10.10.1. Overview
10.10.2. Product Portfolio
10.10.3. Strategic Initiatives
10.10.4. Scot Analysis
10.11. Glysens Inc
10.11.1. Overview
10.11.2. Product Portfolio
10.11.3. Strategic Initiatives
10.11.4. Scot Analysis
10.12. Terumo
10.12.1. Overview
10.12.2. Product Portfolio
10.12.3. Strategic Initiatives
10.12.4. Scot Analysis
10.13. Wockhardt
10.13.1. Overview
10.13.2. Product Portfolio
10.13.3. Strategic Initiatives
10.13.4. Scot Analysis
10.14. I-sens Inc
10.14.1. Overview
10.14.2. Product Portfolio
10.14.3. Strategic Initiatives
10.14.4. Scot Analysis
10.15. Morpen Laboratories Ltd.
10.15.1. Overview
10.15.2. Product Portfolio
10.15.3. Strategic Initiative
10.15.4. Scot Analysis
10.16. Apex Biotechnology Corp.
10.16.1. Overview
10.16.2. Product Portfolio
10.16.3. Scot Analysis
10.17. Arkray Inc
10.17.1. Overview
10.17.2. Product Portfolio
10.17.3. Strategic Analysis
10.17.4. Scot Analysis
10.18. B Braun Melsungen Ag
10.18.1. Overview
10.18.2. Product Portfolio
10.18.3. Scot Analysis
10.18.4. Strategic Analysis
10.19. Ascensia
10.19.1. Overview
10.19.2. Product Portfolio
10.19.3. Scot Analysis
10.19.4. Strategic Analysis
Table List
Table 1 Latin America Cgms Market, 2018-2026($ Million)
Table 2 Latin America Smbg Market, 2018-2026 ($ Million)
Table 3 Latin America Cgms Market, By Component Type, 2018-2026($ Million)
Table 4 Latin America Cgms Sensors Market, 2018-2026 ($ Million)
Table 5 Latin America Cgms Transmitters And Receivers Market, 2018-2026 ($ Million)
Table 6 Latin America Cgms Insulin Pump Market, 2018-2026 ($ Million)
Table 7 Latin America Cgms Market, By Application 2018-2026 ($ Million)
Table 8 Latin America Cgms Home Settings Market, 2018-2026 ($ Million)
Table 9 Latin America Cgms Diagnostics And Clinical Market, 2018-2026 ($ Million)
Table 10 Latin America Cgms Hospital Market, 2018-2026 ($ Million)
Table 11 Important Aspects For Use Of Smbg Devices In Home-care Settings
Table 12 Product Matrix For Lancets
Table 13 Latin America Smbg Market, By Component Type, 2018-2026 ($ Million)
Table 14 Latin America Smbg Lancets Market, 2018-2026 ($ Million)
Table 15 Latin America Smbg Home Setting Market, 2018-2026 ($ Million)
Table 16 Latin America Smbg Clinical Market, 2018-2026 ($ Million)
Table 17 Latin America Smbg Hospitals Market, 2018-2026 ($ Million)
Table 18 Latin America Smbg Market, 2018-2026 ($ Million)
Table 19 Latin America Cgms Market Revenue, 2018-2026($ Million)
Figures List
Figure 1 Latin America Cgms Sensors Market, 2018-2026($ Million)
Figure 2 Latin America Cgms Transmitters And Receivers Market, 2018-2026($ Million)
Figure 3 Latin America Cgms Insulin Pump Market, 2018-2026($ Million)
Figure 4 Latin America Cgms Share, By Application 2017 & 2026 (%)
Figure 5 Latin America Cgms Home Setting Market, 2018-2026($ Million)
Figure 6 Latin America Cgms Diagnostics And Clinical Market, 2018-2026($ Million)
Figure 7 Latin America Cgms Hospital Market, 2018-2026($ Million)
Figure 8 Latin America Smbg Market Share, By Component Type 2017 & 2026(%)
Figure 9 Latin America Smbg Test Strips Market, 2018-2026 ($ Million)
Figure 10 Latin America Smbg Test Strips Market, 2018-2026 ($ Million)
Figure 11 Latin America Smbg Glucose Meter Market, 2018-2026 ($ Million)
Figure 12 Latin America Smbg Glucose Meter Market, 2018-2026 ($ Million)
Figure 13 Latin America Smbg Lancets Market, 2018-2026 ($ Million)
Figure 14 Latin America Smbg Market Share, By Application 2017& 2026(Us $ Million)
Figure 15 Latin America Smbg Home Setting Market, 2018-2026 ($ Million)
Figure 16 Latin America Smbg Clinical Market, 2018-2026 ($ Million)
Figure 17 Latin America Smbg Hospitals Market, 2018-2026 ($ Million)
Figure 18 Latin America Ggms Market Share, 2017 & 2026 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report